EUVIMEDEUVIMED entdecken
Crossref

Enhanced Fe( ii )-artemisinin-mediated chemodynamic therapy with efficient Fe( iii )/Fe( ii ) conversion circulation for cancer treatment

Xiao Xu, Yun Wang, Dan Yan, Chunling Ren, Yuqian Cai, Shanting Liao, Lingyi Kong, Chao Han

Biomaterials Science · 2024

DOI: 10.1039/d4bm01095g ↗

Kurz gefasst

Fachartikel in der Zeitschrift Biomaterials Science, 2024. Verfasst von Xiao Xu und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biochemistry and Molecular Biology, School of Medicine, Nanjing University of Chinese Medicine, 138 Xianlin Avenue, Nanjing 210023, PR …. Hauptthemen laut MEDLINE: Artemisinins, Antineoplastic Agents, Nanoparticles, Silicon Dioxide. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 40 Literaturangaben. Gefördert von: State Administration of Foreign Experts Affairs, Fundamental Research Funds for the Central Universities.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Existing strategies to investigate the antitumor effects of artemisinin and its derivatives (ART) are inadequate.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ArtemisininsAntineoplastic AgentsNanoparticlesSilicon DioxideHumansFerrous CompoundsAnimalsMitochondriaFerric CompoundsGlucose OxidaseDrug CarriersMiceFluorocarbonsTransferrinNeoplasmsIronCell Line, TumorPentanes

Substanzen

ArtemisininsAntineoplastic AgentsSilicon DioxideFerrous CompoundsartemisininFerric CompoundsGlucose OxidaseperfluoropentaneDrug CarriersFluorocarbons

Autor:innen und Institutionen

  • Department of Biochemistry and Molecular Biology, School of Medicine, Nanjing University of Chinese Medicine, 138 Xianlin Avenue, Nanjing 210023, PR China.
  • Jiangsu Key Laboratory of Bioactive Natural Product Research and State Key Laboratory of Natural Medicines, School of Traditional Chinese Pharmacy, Center for Analysis and Testing, China Pharmaceutical University, 639 L…

Förderung

  • State Administration of Foreign Experts Affairs
  • Fundamental Research Funds for the Central Universities

Zitieren

APA

Xu, X., Wang, Y., Yan, D., Ren, C., Cai, Y., Liao, S., Kong, L., & Han, C. (2024). Enhanced Fe( ii )-artemisinin-mediated chemodynamic therapy with efficient Fe( iii )/Fe( ii ) conversion circulation for cancer treatment. Biomaterials Science. https://doi.org/10.1039/d4bm01095g

Vancouver

Xu X, Wang Y, Yan D, Ren C, Cai Y, Liao S, et al. Enhanced Fe( ii )-artemisinin-mediated chemodynamic therapy with efficient Fe( iii )/Fe( ii ) conversion circulation for cancer treatment. Biomaterials Science. 2024. doi:10.1039/d4bm01095g

BibTeX
@article{Xu2024,
  author = {Xu, Xiao and Wang, Yun and Yan, Dan and Ren, Chunling and Cai, Yuqian and Liao, Shanting and Kong, Lingyi and Han, Chao},
  title = {Enhanced Fe( ii )-artemisinin-mediated chemodynamic therapy with efficient Fe( iii )/Fe( ii ) conversion circulation for cancer treatment},
  journal = {Biomaterials Science},
  year = {2024},
  doi = {10.1039/d4bm01095g}
}
Kostenlos starten →